New Delhi: Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union (EU) at highest levels and hoped to resolve them soon.
Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.
“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet.
As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).
The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson).
- IIT Mandi develops new tech to make military equipment invisible to radar
- PM urges global investors to explore Indian energy sector
- Budget a ‘silent strike’ on poor by Modi govt: Sonia Gandhi
- We want to diversify ties with India: Russian Ambassador Alipov
- 108 South Koreans on pilgrimage of Buddhist sites in India, Nepal
- Soon, train passengers can order food via WhatsApp